The majority of breast cancers are considered hormone-sensitive due to the presence of estrogen and/or progesterone receptors; for this reason therapeutic strategies interfering with hormone-mediated tumorgenesis have become a cornerstone of breast cancer management paradigm. Here, PGR is linked to breast carcinoma.